Resistência ao tratamento no linfoma de Burkitt: associação com mutações específicas no gene TP53? Treatment resistance in Burkitt's lymphoma: is it associated with specific mutations of the TP53 gene?

O linfoma de Burkitt (LB) surge a partir de uma célula do centro germinativo que perde o controle da proliferação devido à ativação do gene c-myc. A resistência à apoptose é uma causa importante da falha à quimioterapia na maioria dos cânceres e também no LB. A taxa alta de apoptose observada no LB...

Full description

Bibliographic Details
Published in:	Revista Brasileira de Hematologia e Hemoterapia
Main Authors:	Eliane P. S. Magluta, Claudete E. Klumb
Format:	Article
Language:	English
Published:	Elsevier 2008-02-01
Subjects:	Linfoma de Burkitt gene TP53 mutação resistência tratamento Burkitt's lymphoma TP53 gene mutation resistance treatment
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000100011

Similar Items

Designated primers targeted canine TP53 gene hotspot regions
by: Fatimah Abdulmuttaleb Ali, et al.
Published: (2025-08-01)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01)

Linfoma Burkitt del seno esfenoidal en pediatría: Reporte de caso Burkitt Lymphoma of the Sphenoid Sinus in Children: Case Report
by: Jorge Docampo, et al.
Published: (2011-06-01)

Resultados do Tratamento do Linfoma de Burkitt com a Associação de Ciclofosfamida, Vincristina e Methotrexate
by: Wagner Brant Moreira, et al.
Published: (2023-08-01)

The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01)

Recaída de linfoma de Burkitt en paladar
by: Jessica Medina, et al.
Published: (2021-05-01)

Linfoma de Burkitt esporádico en cavidad bucal. Caso clínico// Sporadic Burkitt´s lymphoma in the oral cavity. A clinical case report
by: María Belén Pagola
Published: (2021-01-01)

Recaída de linfoma de Burkitt en paladar2
by: Jessica Medina, et al.
Published: (2021-05-01)

Analysis of TP53 Codon 72 Gene Polymorphism in Patients with Endometriosis in Isfahan
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2011-12-01)

Chromosome 17 abnormalities and mutation of the TP53 gene: correlation between cytogenetics, flow cytometry and molecular analysis in three cases of chronic myeloid leukemia
by: Luize Otero, et al.
Published: (2005-03-01)

The relationship between TP53 Gene Mutation with treatment results in High-Grade Gliomas
by: Bac Thanh Nguyen, et al.
Published: (2024-05-01)

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
by: Stephen L. Abrams, et al.
Published: (2022-02-01)

Mutation analysis of TP53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan.
by: Mian Adnan Kakakhel, et al.
Published: (2021-02-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

Investigation of formalin gas-induced alterations in TP53 gene expression in quail respiratory tract
by: Maha Abdul-Hadi Abdul-Rida Al-Abdula, et al.
Published: (2025-07-01)

Intususcepción intestinal por linfoma de Burkitt en un paciente adulto. Primer reporte en Latinoamérica
by: Alfonso C. Márquez-Ustariz, et al.
Published: (2022-01-01)

In-frame germline TP53 variant impairs p53 oligomerization and predisposes to cancer
by: Lucie Vanikova, et al.
Published: (2025-08-01)

Mutações no gene TP53 em tumores malignos de mama: associação com fatores de risco e características clínico-patológicas, inclusive risco de óbito, em pacientes residentes no Rio de Janeiro TP53 mutation in malignant breast tumors: association with risk factors and clinical-pathological characteristics, including risk of death, in patients from Rio de Janeiro
by: Claudia Vitória de Moura-Gallo, et al.
Published: (2004-06-01)

Exploring the Functions of Mutant p53 through <i>TP53</i> Knockout in HaCaT Keratinocytes
by: Daniil Romashin, et al.
Published: (2024-02-01)

Uma Apreciação do Tumor de Burkitt
by: Joseph Burchenal
Published: (2023-08-01)

TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities
by: Yunfei Huo, et al.
Published: (2023-09-01)

Comparative Analysis of Gene Correlation Networks of Breast Cancer Patients Based on Mutations in TP53
by: Byungkyu Park, et al.
Published: (2022-07-01)

Linfoma de Burkitt: desafíos en el norte de Nampula, Mozambique
by: Yareida Hernández Amaro
Published: (2016-03-01)

Insight of Tp53 Mutations and their effect on Protein in Different Feline and Canine Neoplasms
by: Rashid Saif, et al.
Published: (2016-02-01)

A case report and literature review on TP53 gene mutation in a bladder rhabdomyosarcoma patient
by: Yixuan Li, et al.
Published: (2024-07-01)

High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting
by: Rushikesh S. Joshi, et al.
Published: (2022-12-01)

Linfoma de Burkitt naso-sinusal – Caso clínico
by: Marco Ribeiro Barbosa, et al.
Published: (2011-09-01)

Linfoma de Burkitt en paciente adulto inmunocompetente que se presenta como rotura esplénica espontánea
by: Karen Cecilia Valdés-Díaz, et al.
Published: (2020-10-01)

APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells
by: James Andrew McCubrey, et al.
Published: (2022-02-01)

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
by: Wenshu Li, et al.
Published: (2024-07-01)

Biologia e Patogênese dos Linfomas não Hodgkin de Origem B na Infância: uma Revisão
by: Claudete Esteves Klumb
Published: (2001-09-01)

p53 e as hemopatias malignas
by: Geraldo Barroso Cavalcanti Júnior, et al.
Published: (2002-09-01)

CASES OF DIFFUSE LARGE B-CELL LYMPHOMA WITH FUNCTIONAL INTRON MUTATIONS IN THE TP53 GENE
by: E. N. Voropaeva, et al.
Published: (2020-03-01)

Defining function of wild-type and three patient-specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma
by: Jiangfei Chen, et al.
Published: (2023-06-01)

<i>TP53</i> Gene Therapy as a Potential Treatment for Patients with COVID-19
by: Joe B. Harford, et al.
Published: (2022-03-01)

Acidosis láctica tipo B1 secundaria a linfoma de Burkitt
by: Natalia Jiménez Brenes, et al.
Published: (2011-07-01)

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
by: Fang Ye, et al.
Published: (2021-12-01)

Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
by: Regina Mirgayazova, et al.
Published: (2024-12-01)

Quantitative Analysis of TP53-Related Lung Cancer Based on Radiomics
by: Qiao H, et al.
Published: (2022-12-01)

Linfoma de Burkitt Primário de Mama: Relato de Caso
by: Laís Gomes Ferreira, et al.
Published: (2022-06-01)